Lucera Erick bought SABS
December 16, 2025 · Form 4 insider transaction
Lucera Erick bought 150,000 shares of SAB Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
150,000
Price
$0.00
Total value
N/A
InsiderLucera Erick
RoleOfficer
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateDecember 16, 2025
Filing dateDecember 18, 2025
Shares owned after150,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in two equal annual installments on December 16, 2026 and December 16, 2027.; This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.